Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen-specific membrane phospholipids are molecular patterns of lipids found in the membranes of microbes that are distinct from those present in host cells[1]. The specific combination and arrangement of phospholipids on pathogen membranes, sometimes called the \"phospholipid code,\" may be recognized by the host immune system or exploited by pathogens for survival and infection. These patterns can act as both molecular signatures for immune targeting and as therapeutic targets for novel drugs, including innate immunity peptides that disrupt pathogen membranes[1]. They differ from classic protein receptors or enzymes, representing a \"non-protein\" target class wherein the lipid composition itself is central to biological activity and disease involvement. Potential for therapeutic application exists, though safety and targeting specificity are key challenges[1][2][3][5].\n\nNote: This target refers to a class of lipids and their *pattern/membrane distribution*, not a specific protein, enzyme, or receptor. It acts as a *therapeutic target* primarily via recognition and interaction by drugs or antibodies, not classic receptor-ligand mechanisms. \"Phospholipid code\" is a key concept connecting pathogen-specific membrane lipids to functional and therapeutic relevance[1].
Targeting distinct microbial phospholipids for recognition and destruction (by immune peptides or drugs); Modifying or mimicking the phospholipid code to alter host-pathogen interactions; Disruption of pathogen membrane integrity leading to cell death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen-specific membrane phospholipid.